Osterweis Capital Management Inc Collegium Pharmaceutical, Inc Transaction History

Osterweis Capital Management Inc

  • $1.67 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 13, 2018
SELL
$14.16 - $24.3 $3.23 Million - $5.54 Million
-227,785 Closed
0 $0
Q2 2018

Aug 13, 2018
BUY
$21.79 - $28.29 $1.43 Million - $1.85 Million
65,480 Added 40.34%
227,785 $5.43 Million
Q1 2018

May 14, 2018
BUY
$18.15 - $29.21 $2.95 Million - $4.74 Million
162,305 New
162,305 $4.15 Million

Others Institutions Holding COLL

# of Institutions
254
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Osterweis Capital Management Inc Portfolio

Follow Osterweis Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Osterweis Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email